phosphodiesterase type 5 inhibitors

phosphodiesterase type 5 inhibitors

Drugs used to treat impotence. Examples are SILDENAFIL (Viagra), tadalafil (Cialis) and VARDENAFIL (Levitra).
References in periodicals archive ?
Phosphodiesterase type 5 inhibitors (PDE5) are a group of drugs (sildenafil, tadalafil, vardanafil) that are widely used as a standard treatment for erectile dysfunction (ED) and some of them for pulmonary hypertension as well (sildenafil and tadalafil).
Data from these three trials show that testosterone supplementation yields some benefits, but they were modest, tended to wane toward the end of the year of treatment, and were not as robust as those reported with use of phosphodiesterase type 5 inhibitors.
Pharmacokinetics, pharmacodynamics and efficacy of phosphodiesterase type 5 inhibitors.
Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat.
Tests conducted by the agency "have revealed an alarming variety of undeclared active ingredients in products marketed as dietary supplements," including phosphodiesterase type 5 inhibitors, such as sildenafil; anticoagulants, such as warfarin; beta-blockers, such as propranolol; and anticonvulsants, such as phenytoin, the letter said.
Also, use of other phosphodiesterase type 5 inhibitors (PDE-5i) drugs such as Cialis and Levitra can be harmful for the ear, but results on those drugs are inconclusive.
Key words: Phosphodiesterase type 5 inhibitors, pulmonary arterial hypertension, sildenafil, tadalafil, vardenafil
The availability of phosphodiesterase type 5 inhibitors (PDE5i) has resulted in increasing numbers of patients seeking medical help for erectile function problems, but has also altered dramatically the medical management of ED (Hatzichristou and Pescatori, 2001; Lewis et al.
g furosemide, salicylates and phosphodiesterase type 5 inhibitors, e.
These findings are important not only because women experience major depressive disorder at nearly double the rate of men and because they experience greater resulting sexual dysfunction than men, but also because (they established] that selective phosphodiesterase type 5 inhibitors are effective" for reducing adverse sexual effects in women, Dr.
Phosphodiesterase type 5 inhibitors are relatively safe for treating erectile dysfunction (ED) and may be useful for managing medication-related ED.

Full browser ?